Machine learning-based prediction of antipsychotic efficacy from brain gray matter structure in drug-naive first-episode schizophrenia
Abstract Predicting patient response to antipsychotic medication is a major challenge in schizophrenia treatment. This study investigates the predictive role of gray matter (GM) in short- and long-term treatment outcomes in drug-naive patients with first-episode schizophrenia (FES). A cohort of 104...
Saved in:
Main Authors: | Xiaodong Guo, Enpeng Zhou, Xianghe Wang, Bingjie Huang, Tianqi Gao, Chengcheng Pu, Xin Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Schizophrenia |
Online Access: | https://doi.org/10.1038/s41537-025-00557-6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oral versus long-acting injectable antipsychotic in first episode schizophrenia: A 12 weeks interventional study
by: Ramandeep Kaur, et al.
Published: (2023-04-01) -
Reduced γ-Aminobutyric Acid and Glutamate+Glutamine Levels in Drug-Naïve Patients with First-Episode Schizophrenia but Not in Those at Ultrahigh Risk
by: Junjie Wang, et al.
Published: (2016-01-01) -
Study of Brain-derived Neurotrophic Factor in Drug-naive Patients with Schizophrenia
by: Partik Kaur, et al.
Published: (2024-05-01) -
Sex differences in the peripheral levels of cytokines during 12-month antipsychotic treatment in a drug-naïve schizophrenia spectrum cohort
by: I. Ratke, et al.
Published: (2025-03-01) -
Peripheral tryptophan-kynurenine pathway dysfunction in first-episode schizophrenia
by: Mian Li, et al.
Published: (2025-01-01)